Systems | Development | Analytics | API | Testing

The Internet of Medical Things (IoMT) is growing faster than ever. According to 2026 data from The Business Research Company, the global IoMT market has reached over $124 billion this year and is on track to hit nearly $300 billion by 2030. This growth is happening because healthcare is moving outside hospital walls and into patients' homes through remote monitoring. But for engineering teams, connecting these devices is a massive headache.

The digital healthcare market is undergoing a structural shift. Recent industry data from McKinsey and Statista shows that the global remote patient monitoring market is projected to reach $6.1 billion by 2030. Healthcare providers are rapidly moving away from legacy, episodic care models toward continuous, data-driven disease management. This change is accelerated by significant updates to reimbursement structures and a growing demand for scalable clinical workflows.

I'll be honest: one number from the latest embedded analytics research stopped the entire planning conversation for this webinar. 57% of teams with embedded analytics report no measurable business impact, and that means not low impact or underwhelming impact, but no measurable impact at all.

The Internet of Medical Things (IoMT) is not a subset of consumer IoT. It is not an extension of Industrial IoT either. It is a distinct engineering domain defined by clinical accuracy requirements, patient safety consequences, mandatory regulatory frameworks, and data privacy obligations. IoMT vs consumer IoT vs industrial IoT is therefore not a product categorisation exercise. It is the foundational question every connected medical device team must answer before writing a single line of firmware.

Clinical AI projects usually fail during integration, not development. They work well in controlled environments, but production workflows expose problems. CDS Hooks and FHIR payloads can be inconsistent and incomplete. Engineering teams face a challenge: embedding clinical decision support into existing EHR workflows without disrupting care. The problem is not just about APIs. Teams must manage many things, including CDS Hooks, authentication, and latency constraints.

A dashboard inside an EHR, claims tool, or finance portal is not just reporting. It sits inside a decision path. That changes the bar. With embedded analytics in regulated industries, teams need access control, audit logs, clear metric logic, and a user experience that fits the workflow. Speed matters. So does usability. But compliance-by-design cannot sit after the fact. It has to be built in from the start.

Healthcare is sitting on a paradox. As per healthcare analytics statistics 2026 It generates more data than any other industry, nearly 30 percent of the world’s total data, yet 97 percent of hospital data still goes unused. That gap is exactly where AI and machine learning in healthcare data analytics are changing the game. We are no longer talking about dashboards or retrospective reports.

For healthcare organizations, AI governance is a must-have that can’t be ignored. To safeguard sensitive patient information, healthcare is subject to a variety of different regulations, for example HIPAA in the United States and GDPR in the European Union. As healthcare organizations implement AI, it brings a balance of efficiencies and risks.

The healthcare landscape in 2026 is defined by a paradox. While the global healthcare IT market is projected to skyrocket toward a US$ 961.26 billion valuation by 2030 according to MarketsandMarkets, hospital leaders are finding that the shiny new tool syndrome is a recipe for disaster. McKinsey highlights that while agentic AI and ambient listening are transforming administrative workflows, the foundation, the Hospital Management Software (HMS), remains the most frequent point of failure.